Is AB SCIENCE PARIS (OTCMKTS:ABSCF)’s Fuel Running High? Reports Show Less Sellers

June 20, 2017 - By Marguerite Chambers

The stock of AB SCIENCE PARIS (OTCMKTS:ABSCF) registered a decrease of 6.17% in short interest. ABSCF’s total short interest was 237,100 shares in June as published by FINRA. Its down 6.17% from 252,700 shares, reported previously. With 100 shares average volume, it will take short sellers 2371 days to cover their ABSCF’s short positions.

It closed at $11.4 lastly. It is down 0.00% since June 20, 2016 and is . It has underperformed by 16.70% the S&P500.

More notable recent AB Science (OTCMKTS:ABSCF) news were published by: Globenewswire.com which released: “AB Science announces that CHMP has adopted a negative opinion for masitinib in …” on May 17, 2017, also Reuters.com with their article: “BRIEF-EU Medicines Agency recommends against approval of AB Science …” published on May 19, 2017, Fiercebiotech.com published: “Analysts lay into AB Science after regulatory misstep” on May 15, 2017. More interesting news about AB Science (OTCMKTS:ABSCF) were released by: Fiercebiotech.com and their article: “AB Science trumpets phase 3 ALS data, but investors seem unmoved” published on May 19, 2017 as well as Fiercebiotech.com‘s news article titled: “AB Science jumps 40% as optimism trumps skepticism in wake of PhIII ALS data” with publication date: April 07, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.